Tegretol antigens and antibodies
US4058511A · kind A · utility
18Cited by
3References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 12, 1976 |
| Grant date | Nov 15, 1977 |
| Priority date | — |
| Expiry date | Jan 12, 1996 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/806
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Derivatives of dibenz[b,f]azepine drugs are provided for preparation of antigens and antibodies, the antibodies finding use in immunoassays for the dibenz[b,f]azepine drugs. Specifically, N-oxoaliphatic substituted carbamoyl dibenz[b,f]azepine compounds are provided which are conjugated with antigenic materials and injected into animals for production of antibodies specific for the azepine drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.